Table 4.

Risk ratios for any type, liver, colon, lung, bladder cancer, and lymphoma in type 2 diabetic patients with low and high doses of dipyridamole and aspirin.

	Dipyridamole				Aspirin
	Low dose (≤75 mg)		High dose (>75 mg)		Low dose (≤75 mg)		High dose (>75 mg)
	HR (95% CI)	P value	HR (95% CI)	P value	HR (95% CI)	P value	HR (95% CI)	P value
Any types of cancer	0.87 (0.67–1.12)	.2765	0.74 (0.52–1.04)	.0841	0.79 (0.64–0.98)	.0347	0.49 (0.34–0.70)	.0001
All-cause mortality	0.98 (0.73–1.31)	.8852	0.88 (0.61–1.26)	.4791	1.33 (1.04–1.69)	.0213	0.28 (0.16–0.47)	<.0001
Liver cancer	0.61 (0.38–0.99)	.049	0.28 (0.12–0.66)	.0038	0.56 (0.37–0.83)	.0046	0.14 (0.05–0.39)	.0002
Colon cancer	0.77 (0.30–1.99)	.5934	0.91 (0.31–2.71)	.8707	068 (0.31–1.52)	.3468	0.62 (0.19–1.97)	.4124
Lung cancer	0.84 (0.41–1.75)	.6438	0.38 (0.11–1.29)	.1207	0.81 (0.44–1.49)	.4985	0.61 (0.24–1.55)	.2969
Bladder cancer	1.85 (0.46–7.54)	.389	2.75 (0.60–12.5)	.192	0.28 (0.05–1.66)	.1592	0.28 (0.05–1.66)	.1592
Lymphoma cancer	0.24 (0.03–2.23)	.2103	0.61 (0.07–5.58)	.6626	0.14 (0.02–1.29)	.0826	-	-

All model adjusted variable in Table 1.

CI = confidence interval, HR = hazard ratio.